tradingkey.logo

Procept Biorobotics Corp

PRCT
34.260USD
+2.200+6.86%
收盤 12/22, 16:00美東報價延遲15分鐘
1.91B總市值
虧損本益比TTM

Procept Biorobotics Corp

34.260
+2.200+6.86%

關於 Procept Biorobotics Corp 公司

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Procept Biorobotics Corp簡介

公司代碼PRCT
公司名稱Procept Biorobotics Corp
上市日期Sep 15, 2021
CEOWood (Larry L)
員工數量756
證券類型Ordinary Share
年結日Sep 15
公司地址150 Baytech Drive
城市SAN JOSE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編95134
電話16502329832
網址https://www.procept-biorobotics.com/
公司代碼PRCT
上市日期Sep 15, 2021
CEOWood (Larry L)

Procept Biorobotics Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
863.16K
+2.37%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.36K
+3056.17%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
3.90K
+65.22%
Ms. Alaleh Azarkhish Nouri
Ms. Alaleh Azarkhish Nouri
Executive Vice President, Chief Legal Officer, Corporate Secretary
Executive Vice President, Chief Legal Officer, Corporate Secretary
--
--
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
863.16K
+2.37%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.36K
+3056.17%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Hand pieces and other consumables
49.13M
62.05%
System sales and rentals
25.03M
31.61%
Service
5.02M
6.34%
地區USD
名稱
營收
佔比
United States
69.58M
87.88%
Outside United States
9.60M
12.12%
業務
地區
業務USD
名稱
營收
佔比
Hand pieces and other consumables
49.13M
62.05%
System sales and rentals
25.03M
31.61%
Service
5.02M
6.34%

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.12%
The Vanguard Group, Inc.
9.29%
BlackRock Institutional Trust Company, N.A.
6.67%
AllianceBernstein L.P.
6.12%
T. Rowe Price Investment Management, Inc.
3.67%
其他
60.13%
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.12%
The Vanguard Group, Inc.
9.29%
BlackRock Institutional Trust Company, N.A.
6.67%
AllianceBernstein L.P.
6.12%
T. Rowe Price Investment Management, Inc.
3.67%
其他
60.13%
股東類型
持股股東
佔比
Investment Advisor
63.63%
Investment Advisor/Hedge Fund
32.62%
Individual Investor
4.43%
Research Firm
3.93%
Hedge Fund
2.68%
Bank and Trust
2.31%
Pension Fund
0.76%
Venture Capital
0.66%
Family Office
0.08%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
536
55.75M
99.78%
-1.67M
2025Q2
535
55.45M
100.20%
-990.27K
2025Q1
539
53.99M
97.68%
-2.82M
2024Q4
499
53.70M
99.42%
+875.53K
2024Q3
449
49.13M
94.16%
-1.41M
2024Q2
393
47.17M
91.61%
-2.29M
2024Q1
345
48.36M
95.04%
-4.45M
2023Q4
326
47.80M
94.81%
-4.63M
2023Q3
322
46.77M
93.30%
+2.15M
2023Q2
298
38.23M
84.44%
-1.74M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Fidelity Management & Research Company LLC
7.70M
13.85%
-416.21K
-5.13%
Jun 30, 2025
The Vanguard Group, Inc.
5.24M
9.41%
+120.94K
+2.36%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.73M
6.7%
+279.11K
+8.09%
Jun 30, 2025
AllianceBernstein L.P.
2.16M
3.88%
+13.16K
+0.61%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.53M
2.75%
+112.42K
+7.94%
Jun 30, 2025
Westfield Capital Management Company, L.P.
1.60M
2.87%
+849.79K
+113.52%
Jun 30, 2025
Mackenzie Investments
708.66K
1.27%
+708.66K
--
Jun 30, 2025
Champlain Investment Partners, LLC
1.07M
1.92%
+394.45K
+58.33%
Jun 30, 2025
Artisan Partners Limited Partnership
986.25K
1.77%
+46.80K
+4.98%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Global X HealthTech ETF
1.64%
State Street SPDR S&P Health Care Equipment ETF
1.62%
ALPS Disruptive Technologies ETF
0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.7%
Global X Robotics & Artificial Intelligence ETF
0.7%
Main Thematic Innovation ETF
0.46%
Harbor Health Care ETF
0.35%
Langar Global HealthTech ETF
0.32%
iShares U.S. Medical Devices ETF
0.22%
Nuveen ESG Small-Cap ETF
0.17%
查看更多
Global X HealthTech ETF
佔比1.64%
State Street SPDR S&P Health Care Equipment ETF
佔比1.62%
ALPS Disruptive Technologies ETF
佔比0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比0.7%
Global X Robotics & Artificial Intelligence ETF
佔比0.7%
Main Thematic Innovation ETF
佔比0.46%
Harbor Health Care ETF
佔比0.35%
Langar Global HealthTech ETF
佔比0.32%
iShares U.S. Medical Devices ETF
佔比0.22%
Nuveen ESG Small-Cap ETF
佔比0.17%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Procept Biorobotics Corp的前五大股東是誰?

Procept Biorobotics Corp的前五大股東如下:
Fidelity Management & Research Company LLC
持有股份:7.70M
佔總股份比例:13.85%。
The Vanguard Group, Inc.
持有股份:5.24M
佔總股份比例:9.41%。
BlackRock Institutional Trust Company, N.A.
持有股份:3.73M
佔總股份比例:6.70%。
AllianceBernstein L.P.
持有股份:2.16M
佔總股份比例:3.88%。
T. Rowe Price Investment Management, Inc.
持有股份:1.53M
佔總股份比例:2.75%。

Procept Biorobotics Corp的前三大股東類型是什麼?

Procept Biorobotics Corp 的前三大股東類型分別是:
Fidelity Management & Research Company LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

有多少機構持有Procept Biorobotics Corp(PRCT)的股份?

截至2025Q3,共有536家機構持有Procept Biorobotics Corp的股份,合計持有的股份價值約為55.75M,占公司總股份的99.78% 。與2025Q2相比,機構持股有所增加,增幅為-0.42%。

哪個業務部門對Procept Biorobotics Corp的收入貢獻最大?

在FY2025Q2,Hand pieces and other consumables業務部門對Procept Biorobotics Corp的收入貢獻最大,創收49.13M,占總收入的62.05% 。
KeyAI